LEONABIO Trademark

Trademark Overview

On Monday, June 8, 2026, a trademark application was filed for LEONABIO with the United States Patent and Trademark Office. The USPTO has given the LEONABIO trademark a serial number of 99871191. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 8, 2026. This trademark is owned by LEONABIO, INC.. The LEONABIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis; Pharmaceutical preparations for the prevention of cancer
leonabio

General Information

Serial Number99871191
Word MarkLEONABIO
Filing DateMonday, June 8, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, June 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis; Pharmaceutical preparations for the prevention of cancer
Pseudo MarkLEONA BIOGRAPHY
Pseudo MarkLEONA BIO
Pseudo MarkLEONA BIOLOGICAL

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 8, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLEONABIO, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98011
US

Trademark Events

Event DateEvent Description
Monday, June 8, 2026NEW APPLICATION ENTERED
Monday, June 8, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 8, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

leonabio disease pharmaceutical preparations insomnia depression stroke schizophrenia pain hearing cancer